鼻部Mohs术后插入皮瓣修复的患者生活质量:多中心前瞻性队列研究
这项多中心前瞻性调查研究纳入169例接受Mohs显微手术及二期插入皮瓣修复的鼻部皮肤癌患者,使用皮肤癌指数(SCI)在四个时间点评估生活质量。完成基线与皮瓣拆除后16周评估的147例患者中,SCI总分平均提高13%(7.11分,95%CI 5.48-8.76,P<.001),情绪、外观和社会三个亚量表均显著改善。
要点
- 鼻部皮肤癌Mohs术后行插入皮瓣修复,患者生活质量在术后16周平均改善。
- SCI总分平均提高7.11分(95%CI 5.48-8.76,P<.001),相对基線增加13%。
- 情绪、外观和社会三个亚量表评分均显著提高(P<.001)。
核心结论
- 鼻部皮肤癌患者接受Mohs显微手术及插入皮瓣修复后,生活质量在皮瓣拆除后16周较术前平均改善。
研究设计与样本
- 多中心前瞻性调查研究,纳入169例18岁及以上鼻部皮肤癌患者,来自美国8个门诊Mohs手术点(学术中心与私人执业),招募时间2018年8月9日至2020年2月2日。
- 使用经验证的15题皮肤癌指数(SCI)问卷,在Mohs术前、皮瓣放置后1周、皮瓣拆除后4周和皮瓣拆除后16周共4个时间点评估。
- 主要结局为Mohs术前与皮瓣拆除后16周总体SCI评分的平均差异;147例患者完成了这两个时间点的问卷。
主要发现
- 完成基线与皮瓣拆除后16周评估的147例患者中,男性75例(51.0%),平均(标准差)年龄67.8(11.7)岁。
- 皮瓣拆除后16周总体SCI评分较术前显著提高,平均增加7.11分(95%CI 5.48-8.76,P<.001),相对增加13%。
- 情绪亚量表平均增加3.27分(95%CI 2.35-4.18,P<.001),外观亚量表平均增加1.65分(95%CI 1.12-2.18,P<.001),社会亚量表平均增加2.10分(95%CI 1.55-2.84,P<.001)。
临床怎么用
- 转诊行Mohs显微手术的医生可告知患者,即使需要复杂重建,术后生活质量平均会改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Single-center studies have shown that patients report better skin cancer-specific quality of life (QOL) after Mohs micrographic surgery (MMS), but it is unclear whether this improved QOL applies to patients after MMS and complex reconstruction in cosmetically sensitive areas. OBJECTIVE: To evaluate patient QOL after MMS and interpolation flap reconstruction for patients with nasal skin cancers. DESIGN, SETTING AND PARTICIPANTS: This multicenter prospective survey study used the Skin Cancer Index (SCI), a validated, 15-question QOL questionnaire administered at 4 time points: before MMS, 1 week after flap placement, 4 weeks after flap takedown, and 16 weeks after flap takedown. Patients age 18 years or older with a nasal skin cancer who presented for MMS and were anticipated to undergo 2-stage interpolated flap repair by a Mohs surgeon were recruited from August 9, 2018, to February 2, 2020, at 8 outpatient MMS locations across the United States, including both academic centers and private practices. MAIN OUTCOMES AND MEASURES: Mean difference in overall SCI score before MMS vs 16 weeks after flap takedown. RESULTS: A total of 169 patients (92 men [54.4%]; mean [SD] age, 67.7 [11.4] years) were enrolled, with 147 patients (75 men [51.0%]; mean [SD] age, 67.8 [11.7] years) completing SCI surveys both before MMS and 16 weeks after flap takedown. Total SCI scores improved significantly 16 weeks after flap takedown compared with pre-MMS scores, increasing by a mean of 13% (increase of 7.11 points; 95% CI, 5.48-8.76; P < .001). All 3 SCI subscale scores (emotion, appearance, and social) improved significantly (emotion subscale, increase of 3.27 points; 95% CI, 2.35-4.18; P < .001; appearance subscale, increase of 1.65 points; 95% CI, 1.12-2.18; P < .001; and social subscale, increase of 2.10 points; 95% CI, 1.55-2.84; P < .001) 16 weeks after flap takedown compared with pre-MMS. CONCLUSIONS AND RELEVANCE: Removal of a nasal skin cancer and repair of the resulting defect can be distressing for patients. However, this cohort study suggests that physicians referring patients for MMS can be reassured that their patient's QOL will improve on average after surgery, even when a complex reconstruction is required.
引用
- Lukowiak TM, Perz AM, Veerabagu SA, et al. Patient Quality of Life After Interpolated Flap Repair of Nasal Mohs Surgery Defects: A Multicenter Prospective Cohort Study. JAMA Dermatol. 2021. PMID: 34431977. doi:10.1001/jamadermatol.2021.3161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。